Previous Article | Next Article 
Infection and Immunity, October 1998, p. 4651-4655, Vol. 66, No. 10
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Cytotoxic T-Lymphocyte-Mediated Lysis of
Toxoplasma gondii-Infected Target Cells Does Not
Lead to Death of Intracellular Parasites
Keizo
Yamashita,1
Katsuyuki
Yui,1,*
Masakatsu
Ueda,1 and
Akihiko
Yano2
Department of Medical Zoology, Nagasaki
University School of Medicine, 1-12-4 Sakamoto, Nagasaki, Nagasaki
852-8523,1 and
Department of
Parasitology, Chiba University School of Medicine, 1-8-1 Inohana,
Chuo-ku, Chiba 260-8670,2 Japan
Received 22 December 1997/Returned for modification 19 February
1998/Accepted 23 July 1998
 |
ABSTRACT |
CD8+ T cells play a crucial role in the control of
infection with intracellular microbes. The mechanisms
underlying the CD8+ T-cell-mediated clearance of
the intracellular pathogen Toxoplasma gondii are, however,
not completely understood. The effect of CD8+ cytotoxic
T-lymphocyte (CTL)-mediated lysis of host cells on the viability of
intracellular T. gondii was investigated. Quantitative competitive PCR of the gene encoding T. gondii major
surface antigen (SAG-1) was combined with treatment of the parasites
with DNase, which removed the DNA template of nonviable parasites. The
induction by CD8+ CTLs of apoptosis in cells infected with
T. gondii did not result in the reduction of live
parasites, indicating that intracellular T. gondii remains
alive after lysis of host cells by CTLs.
 |
INTRODUCTION |
Toxoplasma gondii is an
obligate intracellular protozoan parasite that infects all warm-blooded
animals, including humans. After the primary infection in an
immunocompetent individual, the immune response of the host limits the
replication of tachyzoites, resulting in the formation of the
bradyzoite form, a dormant stage of the parasite. Because of this
effective immune reaction against parasites, chronic infection of an
immunocompetent individual with T. gondii is usually
asymptomatic (3). However, in patients with AIDS as well as
other immunocompromised states, reactivation of chronic toxoplasmosis
results in excessive cellular destruction, often leading to severe
morbidity and mortality (10).
Protective immune responses against infection with T. gondii
have been studied with experimental murine systems. Vaccination with an
attenuated mutant (22, 24) or irradiated tachyzoites (18, 25) induces protective responses against subsequent
infection with the virulent RH strain. CD8+ T-cell-mediated
immunity is one of the major protective mechanisms. Mice primed with
T. gondii succumb to lethal infection when depleted of
CD8+ T cells prior to challenge infection, and host
resistance can be adoptively transferred to naive animals by primed
CD8+ T cells (22, 25) or by CD8+
T-cell clones specific for T. gondii major surface antigen
(SAG-1) (8). However, the underlying mechanisms of
CD8+ cell-mediated protective immunity are not completely
understood. The protection depends on the presence of gamma interferon,
which can be secreted by CD8+ as well as CD4+
cells (8, 23). T. gondii-specific
CD8+ T cells also lyse parasite-infected target cells in a
class I major histocompatibility complex-restricted manner (7, 11, 14, 21, 26). Lysis of host cells may directly damage
intracellular microbes or simply release viable parasites into the
extracellular space. Apoptosis of infected host cells induced either
chemically (13) or by CD8+ cytotoxic T
lymphocytes (CTL) (20) appears to be coupled to damage to
intracellular mycobacteria. Little is known, however, about the fate of
T. gondii parasites in host cells lysed by CD8+
CTL.
The present study was therefore designed to determine whether
CD8+ CTL-mediated lysis of host cells is associated with
the killing of intracellular T. gondii tachyzoites. We
developed a novel method to determine the number of live T. gondii parasites within host cells undergoing apoptosis. We used a
combination of DNase treatment of the samples prior to DNA extraction,
which removed DNA within dead parasites, and quantitative competitive
PCR (QC-PCR) of the T. gondii SAG-1 gene (12).
The results indicated that CD8+ CTL-mediated apoptosis of
target cells does not lead to the death of intracellular T. gondii tachyzoites.
 |
MATERIALS AND METHODS |
Animals, parasites, and cell lines.
BALB/cAnNCrj and
C57BL/6NCrj mice and Lewis/Crj rats were purchased from Charles River
Japan (Kanagawa, Japan). Animals were housed in the Laboratory Animal
Center for Biomedical Research at the Nagasaki University School of
Medicine (Nagasaki, Japan) and were used at 8 to 10 weeks of age.
T. gondii RH was maintained as previously described
(16, 26). M12-neo-1 cells were generated by stable
transfection of M12.4.1 cells (a gift from L. Glimcher, Harvard Medical
School, Boston, Mass.) (9) with linearized Rc/CMV
(Invitrogen, Carlsbad, Calif.) by use of a Gene Pulser (Bio-Rad,
Hercules, Calif.). Transfectants were selected in culture medium
containing G418 (0.5 mg/ml) (Gibco BRL, Grand Island, N.Y.) and cloned
by a limiting-dilution method.
H-2d-specific CTL lines were established from
nonadherent splenocytes of C57BL/6 mice by repeated stimulation with
X-ray-irradiated (20 Gy) BALB/c splenocytes in RPMI 1640 (Gibco BRL)
supplemented with 10% fetal bovine serum (FBS) (Gibco BRL), 100 U of
penicillin per ml, 100 µg of streptomycin per ml, 50 µM
mercaptoethanol, and 20 U of human recombinant interleukin 2 (Shionogi,
Osaka, Japan) per ml. These T cells expressed the T-cell-receptor
chain and were of the CD3+ CD4
CD8+ phenotype (data not shown). The cytolytic activity of
the T-cell lines was determined by a standard 51Cr release
assay as described previously (1). The percentages of
specific 51Cr release by M12.4.1
(H-2d), P815 mastocytoma
(H-2d), and EL4 thymoma
(H-2b) cells at an effector/target cell ratio of
2.5:1 were 74, 69, and 1%, respectively, indicating that these cell
lines were specific for H-2d.
To induce CTL specific for T. gondii, BALB/c mice were
primed twice by intraperitoneal inoculations with T. gondii
RH tachyzoites (107/mouse) which had been inactivated by
treatment with mitomycin C (200 µg/ml) for 2 h at 37°C. Two
weeks after the final priming, mice were sacrificed and spleens were
removed. After lysis of erythrocytes, spleen cells (4 × 106/ml) were cultured for 5 days in the presence of
mitomycin C-treated T. gondii tachyzoites
(106/ml) to induce CTL specific for T. gondii.
DNase treatment of killed T. gondii and DNA
preparation.
Complement-mediated killing of free tachyzoites
(105) was performed at 37°C for 30 min with rat
anti-T. gondii serum prepared from a Lewis rat after priming
with X-ray-irradiated (120 Gy) RH tachyzoites and with rabbit
complement. The trypan blue dye exclusion test indicated that 100% of
the parasites treated with antibody plus complement were dead after the
treatment (data not shown). Cells were incubated in phosphate-buffered
saline (PBS) containing DNase (50 µg/ml) for 30 min at 37°C. After
the cells were washed once with PBS, genomic DNA was prepared with
DNAzol (Gibco BRL) in accordance with the manufacturer's instructions. Glycogen (10 µg) (Boehringer GmbH, Mannheim, Germany) was included in
the DNAzol solution as a carrier.
Preparation of DNA from T. gondii-infected target
cells after CD8+ T-cell-mediated cytolysis.
M12-neo-1
cells were infected with tachyzoites at a multiplicity of infection of
3:1 for 2 h at 37°C. Free tachyzoites were removed from infected
cells by two rounds of low-speed centrifugation (70 × g for 10 min) followed by use of a magnetic cell separation system (Miltenyi Biotec, Bergisch Gladbach, Germany). The infected cells were incubated with rat anti-T. gondii serum at 4°C
for 10 min. After being washed with PBS, the cells were incubated with
microbeads coated with mouse anti-rat immunoglobulins (20 µl of
magnetic probes per 106 cells) in 1 ml of PBS containing
0.5% bovine serum albumin and 0.1 mM EDTA at 8°C for 20 min. Free
tachyzoites were subsequently removed in a magnet field of 0.6 T with
an MS column (Miltenyi Biotec) in which the flowthrough fraction was
collected. The number of contaminating free tachyzoites was less than
2% of M12-neo-1 cells, as determined by light microscopy. The
proportion of the cells infected with T. gondii was 40 to
50%. After coculturing of infected M12-neo-1 cells (104)
with CTL (105), samples were treated with DNase (50 µg/ml) for 30 min at 37°C and DNA was extracted. In some
experiments (see Fig. 3), T. gondii-infected M12-neo-1 cells
were passed through a 30-gauge needle several times to force the
intracellular parasites out of the parasitophorous vacuoles as
described previously (4). The materials were treated or not
treated with anti-T. gondii serum and complement before DNase treatment.
QC-PCR of SAG-1 and Neo genes.
The number of parasites was
determined by QC-PCR of the SAG-1 gene as previously described
(12). Briefly, genomic DNA (<1 µg) extracted from
T. gondii or infected cells was coamplified with a constant
amount of competitor DNA (i.e., approximately 90 copies of the
truncated SAG-1 gene) by use of a set of SAG-1-specific primers for 36 cycles in a final volume of 50 µl in a TSR-300 thermal sequencer
(IWAKI Glass Co. Ltd., Chiba, Japan). The amplified products were
separated by agarose gel electrophoresis and stained with ethidium
bromide. The ratios of the staining intensities of the amplified target
and competitor sequences were determined by densitometry (IPLab Gel
densitometer; Signal Analytical Corp., Vienna, Va.). By comparing the
ratio thus obtained to a standard curve, the copy number of SAG-1 DNA
was calculated. The detection limit was seven copies of SAG-1 DNA per
sample. Because SAG-1 is a single-copy gene, the copy number of SAG-1
DNA is equal to the number of T. gondii tachyzoites. The
results were expressed as the mean parasite number per template DNA,
corresponding to 100 input tachyzoites or 300 infected M12-neo-1
cells ± 1 standard deviation (SD). For statistical comparisons of
two groups, an unpaired two-tailed Student's t test was
used. A P value of <0.05 was considered significant.
The number of live M12-neo-1 cells was determined by QC-PCR of the Neo
gene. Heterologous competitor DNA was constructed by PCR with a
BamHI/EcoRI fragment of the v-erbB
gene as a template by use of a PCR MIMIC construction kit (Clontech
Laboratories, Inc., Palo Alto, Calif.). This DNA fragment was amplified
with a pair of oligonucleotides
(5'-GAGAGGCTATTCGGCTATGACTGGATCCCCGCAAGTGAAATCTC-3' and
5'-ACTCGTCAAGAAGGCGATAGAAGTGATTCTGGACCATGGCAGT-3') which
contained 23-bp Neo gene sequences at the 5' end of the
v-erbB gene sequence, resulting in the generation of a
509-bp sequence within two Neo gene primers. The DNA within the Neo
gene sequences was amplified with a pair of primers
(5'-GAGAGGCTATTCGGCTATGACTG-3' and
5'-ACTCGTCAAGAAGGCGATAGAAG-3') (nucleotides 49 to 71 and 766 to 787, respectively) (19). The target and competitor
sequences were 739 and 558 bp, respectively. A constant amount
(approximately 2 × 10
3 amol) of competitor DNA was
added to the 50-µl PCR mixture (38 cycles) containing template DNA.
The amplified products were resolved by agarose gel electrophoresis and
stained, and the ratios of the staining intensities of the target and
competitor sequences were determined by densitometry. The results were
expressed as the mean number of M12-neo-1 cells per template DNA,
corresponding to 300 input target cells ± 1 SD.
 |
RESULTS |
Estimation of the number of live T. gondii organisms by
QC-PCR.
The number of intracellular T. gondii organisms
can be quantitated by plotting the ratios of the sequence of the QC-PCR
product of T. gondii SAG-1 and its competitor sequences
against a standard curve (12). Initially, we examined
whether this method can selectively amplify DNA of viable parasites.
DNA extracted from free viable tachyzoites and those killed by
anti-T. gondii serum plus complement was used to determine
the number of T. gondii organisms by QC-PCR (Fig. 1 and
Table 1). The ratios of the amplified target and competitor sequences
did not differ significantly (Fig. 1,
lanes 1 and 3; Table 1; P = 0.207), indicating that the DNA extracted from complement-killed
T. gondii can become a template for PCR, like that extracted
from viable T. gondii. Therefore, we modified this method by
introducing DNase treatment to exclude DNA from dead parasites and
determined whether the number of live parasites can be estimated by
QC-PCR. Free T. gondii was treated with DNase to remove the
DNA template within killed T. gondii, assuming that DNase
can gain access to the DNA within dead but not viable cells. This
pretreatment reduced the amount of the PCR product from dead parasites
more than 100-fold (Fig. 1, lanes 3 and 4; Table 1). This reduction was
selective for dead parasites, because the same treatment did not
significantly reduce the amount of the PCR product from live parasites
(Fig. 1, lane 2; Table 1, P = 0.268). To determine that
this method can be applied to a mixture of live and dead T. gondii, a sample containing a 1:1 mixture of live and dead
parasites was treated with DNase, and the number of viable T. gondii parasites was quantitated by QC-PCR. As expected, the number of SAG-1 gene copies obtained from the DNase-treated samples (88 ± 2) was approximately half that in the untreated samples (163 ± 16) (Fig. 1, lanes 5 and 6; Table 1). In a separate
experiment, we confirmed that the gene copy numbers estimated by this
method had a linear relationship with the ratios of viable parasites within the mixture of dead and live T. gondii (data not
shown). These results indicated that DNase treatment effectively
eliminates the SAG-1 gene within dead T. gondii and that
this method can be applied to the quantitation of live parasites in the
presence of dead T. gondii and host tissue.

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 1.
QC-PCR of DNA from cells treated with DNase. Free
T. gondii organisms were untreated (lanes 1 and 2) or
treated with anti-T. gondii serum and complement (lanes 3 and 4), or both untreated and treated T. gondii organisms
were mixed at 1:1 (lanes 5 and 6). Cells were untreated (lanes 1, 3, and 5) or treated (lanes 2, 4, and 6) with DNase. DNA was extracted and
amplified in the presence of competitor DNA with SAG-1 primers. Each
lane represents QC-PCR of the DNA template corresponding to 100 tachyzoites. M, molecular size marker ( X174 HaeIII
digest); sizes (in bases) are shown at left. Experiments were performed
in triplicate. Similar results were obtained in four independent
experiments.
|
|
Viability of T. gondii in infected CTL target
cells.
We applied this method to determine the fate of
intracellular tachyzoites after the lysis of host cells by
CD8+ CTL. An alloreactive CTL line specific for
H-2d was generated by repeated stimulation of
C57BL/6 lymphocytes with BALB/c spleen cells. The stable cell line
M12-neo-1 was used as a target. The use of a neo transfectant cell line
allowed quantitation of the number of viable target cells in the
presence of CTL. M12-neo-1 cells were infected with T. gondii in vitro. After the removal of free T. gondii,
the infected target cells were incubated with H-2d-specific CTL for 0 to 12 h. Cells were
treated with DNase, and DNA was extracted and subjected to QC-PCR to
determine the number of live T. gondii parasites within the
target cells (Fig. 2). During the initial
8 h of coculturing, the number of tachyzoites within the target
cells did not change significantly. After 8 h, the number
increased, perhaps due to the DNA synthesis of T. gondii
within the infected cells. Interestingly, this increase was observed
even when the target cells were lysed by CTL. We speculate that some of
the parasites within the apoptotic target cells infected and multiplied
within effector CTL. Indeed, light microscopic inspection of the cells
after 12 h of culturing revealed that approximately 8% of the
effector T cells were infected by tachyzoites (data not shown). In the
same experiment, 51Cr release by the target cells reached
84% during 6 h of culturing (Fig. 2). These results indicate that
CTL-mediated lysis of cells infected with tachyzoites does not lead to
the death of the intracellular parasites.

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 2.
Kinetics of the number of viable tachyzoites after host
cells were lysed by CTL. Ten thousand M12-neo-1 cells were infected
with RH tachyzoites (infection rate, 45%) and cultured in the presence
(hatched bars) or absence (open bars) of CTL at an effector/target cell
ratio of 10:1. The reaction was terminated at the times indicated, and
the number of viable tachyzoites was determined by QC-PCR. Results are
shown as the mean parasite number per 300 M12-neo-1 cells initially
placed in the culture ± 1 SD (four samples/group). In the same
experiment, a portion of the infected M12-neo-1 cells was
51Cr labeled, and CTL activity was assessed by the
51Cr release assay. The percentages of specific
51Cr release by the target cells during 4 and 6 h of
culturing were 76 and 84%, respectively. Similar results were obtained
in two independent experiments.
|
|
One caveat of this interpretation is that there remained a possibility
that DNase might not be able to access DNA within cells lysed by CTL
and therefore might be unable to digest DNA of intracellular T. gondii. To rule out this possibility, we determined whether DNase
is able to reach the DNA within lysed target cells (Table 2). The M12-neo-1 cell line was used as a
target for this purpose. Thus, the Neo gene is present in target and
not in effector cells, enabling us to determine the number of viable
target cells in the target cell-effector cell mixture. M12-neo-1 cells
were incubated with alloreactive CTL, and QC-PCR of the Neo gene was
performed with DNA extracted from these cells. Coculturing of M12-neo-1 cells with CTL resulted in the reduction of the Neo gene copy number in
parallel with an increase in 51Cr release by the target
cells. In contrast, M12-neo-1 cells cultured without CTL maintained the
same copy number of the Neo gene after DNase treatment. The comparison
of QC-PCR with 51Cr release suggested that permeability to
DNase may be a more sensitive method than 51Cr release in
determining CTL activity. Thus, DNase is able to access cellular DNA
when target cells are lysed by CTL.
Intracellular T. gondii resides within parasitophorous
vacuoles. It was thus still not clear whether DNase could reach the DNA
of intracellular T. gondii after CTL-mediated lysis of host cells. Thus, we examined the viability of intracellular T. gondii after CTL-mediated lysis of host cells by an alternative
method. We examined whether intracellular T. gondii within
host cells lysed by CTL maintains an intact cell membrane. After
coculturing with CTL, parasites were released from target cells by
mechanical disruption. DNA was extracted from these samples after DNase
treatment and subjected to QC-PCR (Fig.
3). To confirm that dead parasites were
DNase accessible in this experiment, one of the disrupted samples was
treated with anti-T. gondii antibody and complement prior to
DNase treatment. The results indicated that T. gondii within
CTL target cells was resistant to DNase treatment, supporting the
conclusion that the parasites were alive.

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 3.
Resistance of the intracellular T. gondii to
DNase treatment after CTL-mediated lysis of the host cells. M12-neo-1
cells (104) infected with tachyzoites for 15 h
(infection rate, 40%) were cultured in the presence of an
H-2d-specific CTL line at an effector/target
cell ratio of 10:1 for 4 h. The samples were disrupted by repeated
passage through a 30-gauge needle. One of the disrupted samples was
treated with rat anti-T. gondii serum (Ab) and complement
(C). Finally, the samples were treated or not treated with DNase, and
DNA was extracted. QC-PCR of each DNA sample was performed, and the
SAG-1 gene copy number was estimated as described in Materials and
Methods. Mean data from one of two similar independent duplicate
experiments are shown.
|
|
Finally, to determine that intracellular T. gondii was
indeed viable after the lysis of host cells by T. gondii-specific CTL, we determined the numbers of Neo and SAG-1
gene copies in T. gondii-infected M12-neo-1 cells after
incubation with T. gondii-specific CTL and DNase treatment
(Table 3). CTL were induced by
coculturing of primed BALB/c spleen cells with mitomycin C-treated
T. gondii tachyzoites. These CTL were specific for T. gondii because treatment of the T. gondii-infected
target cells with DNase after coculturing with the CTL resulted in a
64% reduction in the Neo gene copy number (137 versus 60), while no
significant reduction was observed when the target cells were not
infected (124 versus 122). The same DNA samples were used to assess the
viability of T. gondii within the target cells. The SAG-1
gene copy number did not change significantly after DNase treatment
(102 versus 110), indicating that intracellular T. gondii
was alive after lysis of the target cells by the T. gondii-specific CTL.
 |
DISCUSSION |
A novel method to selectively quantitate the number of live
T. gondii parasites in a mixture of dead T. gondii and host tissue was developed. The quantitation of live
T. gondii parasites was previously performed by
determining their ability to grow intracellularly or lyse host cells by
a 3H-uracil incorporation assay or a plaque assay,
respectively (15). However, only 20 to 30% of the free
tachyzoites lysed from hosts are infective for other cells, and these
methods are difficult to apply in quantifying viable tachyzoites within
apoptotic host cells, because individual tachyzoites cannot be
segregated from the apoptotic cell, which tends to
clump. Therefore, we used membrane permeability as a measure of cell
viability and overcame these difficulties by a combination of DNase
treatment and QC-PCR, which allowed simple and rapid quantitation of
viable tachyzoites in the cell mixture. This method was applied to
determine whether CD8+ CTL can kill intracellular
tachyzoites when they lyse target cells. The results indicated that
CTL specific for T. gondii are unable to kill intracellular
T. gondii tachyzoites.
The induction of apoptosis in target cells by CD8+ CTL is
mediated by perforin and granzyme B or the engagement of Fas on the target cells (7, 11). In our assay system, it is likely that the lysis of T. gondii-infected target cells was mediated by
perforin and granzyme B, because the CTL used in our assay system are
conventional CD8+ CTL and because M12-neo-1 target cells do
not express Fas (reference 5 and unpublished data). Thus, we
believe that the lysis of T. gondii-infected cells through
the release of cytotoxic granules by CTL does not lead to the death of
intracellular parasites. Indeed, perforin does not appear obligatory
for protection against T. gondii infection, because T. gondii-primed perforin knockout mice retain resistance to
challenge infection with the parasite (2). It is formally
possible that Fas-mediated lysis of host cells has distinct effects on
intracellular T. gondii. We think it is unlikely, however,
because the induction of apoptosis in Fas+ A20 cells
infected with T. gondii by anti-Fas monoclonal antibodies did not kill intracellular parasites (data not shown). Perforin- or
granzyme-mediated lysis of infected macrophages by CTL has been shown
to result in the death of intracellular Mycobacterium tuberculosis, whereas Fas-mediated lysis has not (20).
The discrepancy between our study and theirs may be due to the
differences in the pathogens used (T. gondii versus M. tuberculosis) and in the host species (mouse versus human).
Alternatively, differences in host cells may explain this difference.
We used a B-cell tumor which does not have the phagocytic ability of
apoptotic cells, while they used macrophages as infected targets.
Therefore, the possibility that the death of the intracellular bacteria
was due to the phagocytosis of apoptotic macrophages by
neighboring macrophages was not completely ruled out in their study. It
is also possible that a subset of CD8+ CTL can kill
intracellular T. gondii.
We previously demonstrated that protective immunity against
a virulent strain of T. gondii can be transferred to naive
animals by adoptive transfer of primed CD8+ cells
(25). If CD8+ CTL are not themselves cytotoxic
for intracellular T. gondii, how are tachyzoites cleared in
vivo? The lysis of host cells by CTL may release tachyzoites from their
sequestered environment into the extracellular space, where other
effector molecules and cells are accessible. These include antibody,
complement, NK cells, a population of CD8+ T cells which
are directly parasitocidal (8), and macrophages (6). It is unclear which molecules and cells are the most
critical for clearing tachyzoites after host cell lysis. Alternatively, tachyzoites may be cleared even prior to their release into the extracellular fluid after the induction of host cell apoptosis. Induction of apoptosis by CD8+ T lymphocytes may result in
the phagocytosis of apoptotic cells by macrophages (17),
resulting in enzymatic digestion of the parasites in phagolysosomes.
Thus, one of the roles of CTL may be to prepare infected cells for
engulfment by macrophages. In our CTL assay, only target cells and CTL
were mixed in vitro, and intracellular T. gondii survived
the CTL-mediated lysis of the host cells. We believe that it is likely
that macrophages are involved in the clearance of T. gondii
in vivo. Our preliminary study indeed suggests that this mechanism may
be operative.
 |
ACKNOWLEDGMENTS |
We thank Y. Imamura for help and Y. Hagisaka for technical
assistance. We also thank G. Massey for editorial assistance and I. A. Khan for advice.
This work was supported by a grant-in-aid for scientific research from
the Ministry of Education, Science, Culture and Sports.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Medical Zoology, Nagasaki University School of Medicine, 1-12-4 Sakamoto, Nagasaki, Nagasaki 852-8523, Japan. Phone: 81-95-849-7070. Fax: 81-95-849-7073. E-mail:
katsu{at}net.nagasaki-u.ac.jp.
Editor:
S. H. E. Kaufmann
 |
REFERENCES |
| 1.
|
Aosai, F.,
T. H. Yang,
M. Ueda, and A. Yano.
1994.
Isolation of naturally processed peptides from a Toxoplasma gondii-infected human B lymphoma cell line that are recognized by cytotoxic T lymphocytes.
J. Parasitol.
80:260-266[Medline].
|
| 2.
|
Denkers, E. Y.,
G. Yap,
T. Scharton-Kersten,
H. Charest,
B. A. Butcher,
P. Caspar,
S. Heiny, and A. Sher.
1997.
Perforin-mediated cytolysis plays a limited role in host resistance to Toxoplasma gondii.
J. Immunol.
159:1903-1908[Abstract].
|
| 3.
|
Frenkel, J. K.
1988.
Pathophysiology of toxoplasmosis.
Parasitol. Today
4:273-278.
[Medline] |
| 4.
|
Gazzinelli, R. T.,
F. T. Hakim,
S. Hieny,
G. M. Shearer, and A. Sher.
1991.
Synergistic role of CD4+ and CD8+ T lymphocytes in INF-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine.
J. Immunol.
146:286-292[Abstract].
|
| 5.
|
Hahn, S.,
R. Gehri, and P. Erb.
1995.
Mechanism and biological significance of CD4-mediated cytotoxicity.
Immunol. Rev.
146:57-79[Medline].
|
| 6.
|
Joiner, K. A.,
S. A. Fuhrman,
H. M. Miettinen,
L. H. Kasper, and I. Mellman.
1990.
Toxoplasma gondii: fusion competence of parasitophorous vacuoles in Fc receptor-transfected fibroblasts.
Science
249:641-646[Abstract/Free Full Text].
|
| 7.
|
Kagi, D.,
F. Vignaux,
B. Ledermann,
K. Burki,
V. Depraetere,
S. Nagata,
H. Hengartner, and P. Golstein.
1994.
Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity.
Science
265:528-530[Abstract/Free Full Text].
|
| 8.
|
Khan, I. A.,
K. A. Smith, and L. H. Kasper.
1988.
Induction of antigen-specific parasiticidal cytotoxic T cell splenocytes by a major membrane protein (P30) of Toxoplasma gondii.
J. Immunol.
141:3600-3605[Abstract].
|
| 9.
|
Kim, K. J.,
C. Kanellopoulos-Langevin,
R. Merwin,
D. Sachs, and R. Asofsky.
1979.
Establishment and characterization of BALB/c lymphoma lines with B cell properties.
J. Immunol.
122:549-554[Abstract/Free Full Text].
|
| 10.
|
Levy, R. M.,
D. E. Bredesen, and M. L. Rosenblum.
1995.
Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature.
J. Neurosurg.
62:475-495.
|
| 11.
|
Lowin, B.,
M. Hahne,
C. Mattmann, and J. Tschopp.
1994.
Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways.
Nature
370:650-652[Medline].
|
| 12.
|
Luo, W.-T.,
T. Seki,
K. Yamashita,
F. Aosai,
M. Ueda, and A. Yano.
1995.
Quantitative detection of Toxoplasma gondii by competitive polymerase chain reaction of the surface specific antigen gene-1.
Jpn. J. Parasitol.
44:183-190.
|
| 13.
|
Molloy, A.,
P. Laochumroonvorapong, and G. Kaplan.
1994.
Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guerin.
J. Exp. Med.
180:1499-1509[Abstract/Free Full Text].
|
| 14.
|
Montoya, J. G.,
K. E. Lowe,
C. Clayberger,
D. Moody,
D. Do,
J. S. Remington,
S. Talib, and C. S. Subauste.
1996.
Human CD4+ and CD8+ T lymphocytes are both cytotoxic to Toxoplasma gondii-infected cells.
Infect. Immun.
64:176-181[Abstract].
|
| 15.
|
Roos, D. S.,
R. G. Donald,
N. S. Morrissette, and A. L. Moulton.
1994.
Molecular tools for genetic dissection of the protozoan parasite Toxoplasma gondii.
Methods Cell Biol.
45:27-63[Medline].
|
| 16.
|
Sabin, A. B.
1941.
Toxoplasmic encephalitis in children.
JAMA
116:801-807.
|
| 17.
|
Savill, J.
1996.
Phagocyte recognition of apoptotic cells.
Biochem. Soc. Trans.
24:1065-1069[Medline].
|
| 18.
|
Seah, S. K., and G. Hucal.
1975.
The use of irradiated vaccine in immunization against experimental murine toxoplasmosis.
Can. J. Microbiol.
21:1379-1385[Medline].
|
| 19.
|
Southern, P. J., and P. Berg.
1982.
Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter.
J. Mol. Appl. Genet.
1:327-341[Medline].
|
| 20.
|
Stenger, S.,
R. J. Mazzaccaro,
K. Uyemura,
S. Cho,
P. F. Barnes,
J. P. Rosat,
A. Sette,
M. B. Brenner,
S. A. Porcelli,
B. Bloom, and R. L. Modlin.
1997.
Differential effects of cytolytic T cell subsets on intracellular infection.
Science
276:1684-1687[Abstract/Free Full Text].
|
| 21.
|
Subauste, C. S.,
A. H. Koniaris, and J. S. Remington.
1991.
Murine CD8+ cytotoxic T lymphocytes lyse Toxoplasma gondii-infected cells.
J. Immunol.
147:3955-3959[Abstract].
|
| 22.
|
Suzuki, Y., and J. S. Remington.
1988.
Dual regulation of resistance against Toxoplasma gondii infection by Lyt-2+ and Lyt-1+, L3T4+ T cells in mice.
J. Immunol.
140:3943-3946[Abstract].
|
| 23.
|
Suzuki, Y., and J. S. Remington.
1990.
The effect of anti-IFN-gamma antibody on the protective effect of Lyt-2+ immune T cells against toxoplasmosis in mice.
J. Immunol.
144:1954-1956[Abstract].
|
| 24.
|
Waldeland, H., and J. K. Frenkel.
1983.
Live and killed vaccines against toxoplasmosis in mice.
J. Parasitol.
69:60-65[Medline].
|
| 25.
|
Yamashita, K.,
M. Ueda, and A. Yano.
1996.
CD8+ T-cell mediated protection against acute toxoplasmosis in mice induced with X-ray irradiated Toxoplasma gondii tachyzoites.
Jpn. J. Parasitol.
45:173-180.
|
| 26.
|
Yano, A.,
F. Aosai,
M. Ohta,
H. Hasekura,
K. Sugane, and S. Hayashi.
1989.
Antigen presentation by Toxoplasma gondii-infected cells to CD4+ proliferative T cells and CD8+ cytotoxic cells.
J. Parasitol.
75:411-416[Medline].
|
Infection and Immunity, October 1998, p. 4651-4655, Vol. 66, No. 10
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Wang, X., Kang, H., Kikuchi, T., Suzuki, Y.
(2004). Gamma Interferon Production, but Not Perforin-Mediated Cytolytic Activity, of T Cells Is Required for Prevention of Toxoplasmic Encephalitis in BALB/c Mice Genetically Resistant to the Disease. Infect. Immun.
72: 4432-4438
[Abstract]
[Full Text]
-
Staska, L. M., McGuire, T. C., Davies, C. J., Lewin, H. A., Baszler, T. V.
(2003). Neospora caninum-Infected Cattle Develop Parasite-Specific CD4+ Cytotoxic T Lymphocytes. Infect. Immun.
71: 3272-3279
[Abstract]
[Full Text]
-
Scorza, T., D'Souza, S., Laloup, M., Dewit, J., De Braekeleer, J., Verschueren, H., Vercammen, M., Huygen, K., Jongert, E.
(2003). A GRA1 DNA Vaccine Primes Cytolytic CD8+ T Cells To Control Acute Toxoplasma gondii Infection. Infect. Immun.
71: 309-316
[Abstract]
[Full Text]